Advertisement

Topics

European Biopharmaceutical Enterprises Company Profile

07:42 EDT 20th June 2018 | BioPortfolio

EBE provides a range of services based on the needs of its members, aimed at supporting the biotechnology business model and allowing biotechnology products within Europe to be researched, developed and brought to patients quickly.Through its commitment to encourage better understanding of biotechnology, EBE seeks to provide expert input to the main aspects of the healthcare debate which covers a wide range of scientific, ethical, societal and economic issues related to the activities of the EBE members. EBE is a specialised group within the European Federation of Pharmaceutical Industries and Associations (EFPIA).

Location

Rue du Trône 108 - Leopold Plaza Building
Brussels
B-1050
Belgium

Contact

Phone: 32 2 626 2555
Fax: 32 2 626 2566
Email: info@ebe-biopharma.org


News Articles [603 Associated News Articles listed on BioPortfolio]

EBE reveals Europe’s biosimilar pricing and reimbursement policies landscape

The first biosimilar was approved in the European Union (EU) in 2016. Since then, biosimilar policies have been developed with a focus on increasing biosimilar uptake. However, the extent to which EU ...

Contrasting Nu Skin Enterprises

Nu Skin Enterprises and McKesson are both consumer staples companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, institutional own...

AstraZeneca secures European approval for asthma drug

Biopharmaceutical company AstraZeneca has received approval from the European Commission (EC) for its asthma medicine Fasenra. Results from AstraZeneca's Phase III WINDWARD programme demonstrated a...

HORIZON Particle Analysis Launches in Europe at MIBio 2017

PHILADELPHIA , Oct. 2, 2017 /- Halo Labs announces the European launch of their new low volume, high throughput biopharmaceutical particle analysis system called the HORIZON at MIBio 2017 in Cambri...

Phase II clinical trial for Parkinson’s treatment, THN102, receives first European approval

The first European approval for a Phase II clinical trial with THN102 in Parkinson’s patients has been announced by biopharmaceutical company, Theranexus.

VIAVI Introduces ObserverLIVE.com, SaaS-Based Network Performance Monitoring for Enterprises

Enterprises worldwide are embracing cloud services. In the VIAVI State of the Networksurvey, approximately 80 percent of respondents said they would be using public Read more...

CSE New #Cannabis Listing - MedMen Enterprises Inc. (MMEN); @CSE_News

May 29, 2018 (Investorideas.com Newswire) The Class B Subordinate Voting Shares of MedMen Enterprises Inc. have been approved for listing on the CSE.

DePuy announces Medical Enterprises buy, arthroscopy system launch

A definitive agreement was signed by DePuy Synthes to pay an undisclosed amount for the assets of Medical Enterprises Distrib -More- 

PubMed Articles [1843 Associated PubMed Articles listed on BioPortfolio]

Just how good an investment is the biopharmaceutical sector?

Uncertainty surrounding the risk and reward of investments in biopharmaceutical companies poses a challenge to those interested in funding such enterprises. Using data on publicly traded stocks, we tr...

Study on the ownership balance and the efficiency of mixed ownership enterprises from the perspective of heterogeneous shareholders.

Based on the database data of Chinese industrial enterprises from 2000 to 2007 and the LP method, this paper measures the total factor productivity of enterprises and investigates the effect of differ...

Induced pluripotent stem cells as a biopharmaceutical factory for extracellular vesicles.

Differentiating the effect of social enterprise activities on health.

An emerging stream of literature has focused on the ways in which social enterprises might act on the social determinants of health. However, this previous work has not taken a sufficiently broad acco...

Navigational enterprises in Europe and its empires, 1730-1850.

Clinical Trials [605 Associated Clinical Trials listed on BioPortfolio]

Asili Evaluation in the Democratic Republic of Congo

The South Kivu province of DRC has experience continuous armed conflict over the last several decades; as a result, livelihoods and health metrics are uniformly poor. Thus, the objective o...

A Comparison of European and Chinese Blood Sugar Responses

This study is designed to compare the responses to an oral glucose challenge between people of European and Chinese heritage (essential participants in the European arm must have tow Europ...

What After the First Propess

The aim of this study is to compare three different regimens for continuation of induction of labor after no spontaneous or artificial rupture of membranes could be achieved after first 24...

Phase III Clinical Study of Efficacy and Safety of Vaccae™ to Prevent Tuberculosis

Mycobacterium Vaccae for Injection (Trade Name "Vaccae") is a kind of bio-products developed by Anhui Zhifei Longcom Biopharmaceutical Co.,Ltd.,and got "The New Drug Certificate "in 1999...

Clinical Course of Interstitial Lung Diseases: European IPF Registry and Biobank

Born out of the European Union 7th Framework Programme funded project European IPF Network (eurIPFnet), the European IPF Registry (eurIPFreg) has become Europe's leading database of longit...

Companies [1827 Associated Companies listed on BioPortfolio]

EUROCHAMBRES

EUROCHAMBRES forms one of the key pillars of business representation to the European institutions. Its mission is to represent, serve and promote European Chambers of Commerce and Industry. To strengt...

European Biopharmaceutical Enterprises

EBE provides a range of services based on the needs of its members, aimed at supporting the biotechnology business model and allowing biotechnology products within Europe to be researched, developed a...

UEAPME

UEAPME is the employer's organisation representing the interests of European crafts, trades and SMEs at EU level. UEAPME is a recognised European Social Partner and acts on behalf of crafts and SMEs i...

ERA-Net EuroNanoMed

EuroNanoMed aims at leveraging European Nanomedicine through the support of transnational collaborative and multidisciplinary research and technology development projects with par...

Phaermaceutical Technology

Pharmaceutical Technology Europe (PTE) magazine is the market-leading publication for European professionals actively involved in pharmaceutical/biopharmaceutical development, manufacturing and QA/QC....

More Information about "European Biopharmaceutical Enterprises" on BioPortfolio

We have published hundreds of European Biopharmaceutical Enterprises news stories on BioPortfolio along with dozens of European Biopharmaceutical Enterprises Clinical Trials and PubMed Articles about European Biopharmaceutical Enterprises for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of European Biopharmaceutical Enterprises Companies in our database. You can also find out about relevant European Biopharmaceutical Enterprises Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...


Corporate Database Quicklinks



Searches Linking to this Company Record